MARINUS PHARMACEUTICALS INC's ticker is and the CUSIP is 56854Q200. A total of 106 filers reported holding MARINUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 2,145,337 | $17,269,963 | 7.70% |
| Bleichroeder LP | 1,872,463 | $15,073,327 | 3.72% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,204,942 | $41,899,783 | 2.26% |
| Opaleye Management Inc. | 584,000 | $4,701,200 | 1.53% |
| Bain Capital Life Sciences Investors, LLC | 1,431,058 | $11,520,017 | 1.29% |
| Cormorant Asset Management, LP | 2,625,000 | $21,131,250 | 1.23% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 290,000 | $2,337,400 | 0.79% |
| Ikarian Capital, LLC | 746,069 | $6,005,856 | 0.72% |
| Eventide Asset Management | 4,529,997 | $36,466,476 | 0.66% |
| Altium Capital Management LP | 125,033 | $1,006,516 | 0.52% |
| GMT CAPITAL CORP | 1,722,695 | $13,867,695 | 0.52% |
| Sofinnova Investments, Inc. | 985,606 | $7,934,128 | 0.50% |
| Avoro Capital Advisors LLC | 3,150,000 | $25,357,500 | 0.40% |
| Alpha DNA Investment Management LLC | 77,083 | $620,518 | 0.25% |
| Mach-1 Financial Group, LLC | 68,203 | $549,034 | 0.23% |
| Worth Venture Partners, LLC | 42,400 | $341,320 | 0.20% |
| Sofinnova Investments, Inc. | 320,600 | $2,580,830 | 0.16% |
| Simplify Asset Management Inc. | 150,000 | $1,207,500 | 0.14% |
| ACUTA CAPITAL PARTNERS, LLC | 19,500 | $156,975 | 0.10% |
| BOOTHBAY FUND MANAGEMENT, LLC | 453,872 | $3,653,670 | 0.09% |
This page lists MARINUS PHARMACEUTICALS INC's shareholders in Q3 2023. To view MARINUS PHARMACEUTICALS INC's shareholder history, click here.